a monoclonal antibody used to treat certain types of head and neck cancer, and colorectal cancer that has spread to other parts of the body. it is also being studied in the treatment of other types of cancer. monoclonal antibodies are made in the laboratory and can locate and bind to cancer cells. cetuximab binds to the epidermal growth factor receptor (egfr), which is found on the surface of some types of cancer cells. also called erbitux.
出典:Wikipedia
出典:『Wikipedia』 (2011/07/31 03:16 UTC 版)
Cetuximab (IMC-C225—marketed under the name Erbitux) is a chimeric (mouse/human) monoclonal antibody, an epidermal growth factor receptor (EGFR) inhibitor, given by intravenous infusion for treatment of metastatic colorectal cancer and head and neck cancer.